http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200099621-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0314c17f8ea3bab5fd7bba8cdda11ac2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-06013
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-06013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
filingDate 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d39b3eb590443a103de308a3a250c96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a27ef78146e87f87d516fdc6bf55c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f052e5b9abff0b5d9413395b72f78a7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d03c879e8e92a2c93117346b7a07653f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0eb019b708f54baf0281415b08a487e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e7a5c427a26beb7209ebea51dbb495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73a8156391f31f80295528bde4861356
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e529ae0f7bcec4fe93a0611579643a1
publicationDate 2020-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20200099621-A
titleOfInvention Methods and compositions for treating hunter syndrome
abstract The present invention, in particular, provides a composition and method for CNS delivery of a human recombinant iduronate-2-sulfatase protein, idusulfase-beta, for effective treatment of Hunter syndrome. The compositions and methods provided by the present invention effectively reduce symptoms in the brain and spinal cord, as well as in peripheral tissues including the heart, liver, spleen, lungs and kidneys.
priorityDate 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011163648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015320843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013148277-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014271598-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448762104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450185610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22418719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50909322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451774801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130176626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421213797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450210835
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15931
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21893726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448899743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449097368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423387664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414801397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061

Total number of triples: 66.